← Open Payments lookup

CHARLES OKPARA: Open Payments

NPI 1174187744 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 28 payments from 11 companies in 2025. Trend: 2023 $1,097 · 2024 $970 · 2025 $899

Food & beverage: $899
CompanyPaymentsAmount
Incyte Corporation8$481
Merck Sharp & Dohme LLC5$92
PFIZER INC.4$86
Regeneron Healthcare Solutions, Inc.2$51
Gilead Sciences, Inc.2$43
Syndax Pharmaceuticals, Inc.1$33
Janssen Biotech, Inc.2$33
Astellas Pharma US Inc1$22
Novartis Pharmaceuticals Corporation1$20
Exelixis Inc.1$20

Products named: Monjuvi, Zynyz, KEYTRUDA, Xtandi, LIBTAYO, Trodelvy, TECVAYLI, INLYTA.

Industry payments across TX — which companies pay providers there.